Rosen, a leading and top ranked law firm, encourages unicycive therapeutics, inc. investors to secure counsel before important october 14 deadline in securities fraud lawsuit – uncy

New york, oct. 12, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of unicycive therapeutics, inc. (nasdaq: uncy) between march 29, 2024 and june 27, 2025, both dates inclusive (the “class period”), of the important october 14, 2025 lead plaintiff deadline.
TOP Ratings Summary
TOP Quant Ranking